A multicenter standard of care-controlled study to evaluate the long-term safety of bicifadine for the treatment of chronic low back pain
Phase of Trial: Phase III
Latest Information Update: 26 Mar 2007
At a glance
- Drugs Bicifadine (Primary)
- Indications Back pain
- Focus Adverse reactions; Therapeutic Use
- Sponsors Euthymics Bioscience
- 13 Oct 2006 The expected completion date for this trial is now 1 Jan 2007.
- 18 May 2006 New trial record.